Originally, the only interest in C-peptide was as being a marker of insulin secretion and it has, as such, been of good value in furthering the understanding of the pathophysiology of sort 1 and type two diabetic issues. The first documented use on the C-peptide examination was in 1972.[5] In https://aestheticdermalpharma.com/